Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid Malignancies

Stopped The landscape of treatment for patients targeted for enrollment has significantly changed since the protocol was written and approved, and the research treatment is no longer the best option for this population.

Conditions

• B-Cell Lymphoid Malignancies
• Hematologic Malignancy
• Non-Hodgkin Lymphoma

Interventions

• BIOLOGICAL: Hematopoietic Stem Cells from HLA-compatible Related
• BIOLOGICAL: Hematopoietic Stem Cells from HLA Unrelated

Sponsor

Baptist Health South Florida